While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug Administration in July.

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in ...

The prostate is a small gland in males that aids in reproduction. Prostate cancer is one of the most common types of cancer, ...

Drug treatments for blood cancers have evolved. In the past, myeloma patients received two drugs in sequence—two after two.

Prostate cancer, which develops in the prostate gland, primarily affects older men, but younger men with a family history are ...

Eating more than 100g of red meat daily might increase the risk of developing colorectal cancer by 17 percent, the Health ...

Blood tests for cancer detection, known as liquid biopsies, can still be unreliable, but progress is being made. Competition between different diagnostics companies is also intensifying.

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.